The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers

The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This p...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 11; no. 11; p. 3031
Main Authors Donica, Vlad Constantin, Alexa, Anisia Iuliana, Pavel, Irina Andreea, Danielescu, Ciprian, Ciapă, Manuela Andreea, Donica, Alexandra Lori, Bogdănici, Camelia Margareta
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 01.11.2023
Subjects
Angiography
Atrophy
Biological markers
Biomarkers
Central nervous system
demyelinating disease
Developing countries
Inflammation
LDCs
Medical research
Medicine, Experimental
Multiple sclerosis
Neurodegeneration
OCT
OCT-A
Optic nerve
optical coherence tomography
optical coherence tomography angiography
Optics
Pathophysiology
Patients
Retina
Tomography
Online AccessGet full text

Cover

More Information
Summary:The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines11113031